We hypothesise that increased physiological levels of circulating thyroid hormone promote cell growth and invasiveness in both type I and type II endometrial cancers, while reduced concentrations, as seen in clinical hypothyroidism, have the opposite effect. This evidence concerns the gene TG and hypothyroidism.